• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力与视神经脊髓炎中神经自身免疫血清学标志物的共存。

Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica.

作者信息

McKeon Andrew, Lennon Vanda A, Jacob Anu, Matiello Marcelo, Lucchinetti Claudia F, Kale Nilufer, Chan Koon H, Weinshenker Brian G, Apiwattinakul Metha, Wingerchuk Dean M, Pittock Sean J

机构信息

Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

出版信息

Muscle Nerve. 2009 Jan;39(1):87-90. doi: 10.1002/mus.21197.

DOI:10.1002/mus.21197
PMID:19086079
Abstract

We systematically evaluated the frequency of neurological disorders and muscle and neural autoantibodies in 177 patients with neuromyelitis optica (NMO) and in 250 control subjects (173 healthy; 77 multiple sclerosis, MS, patients). An excess of myasthenia gravis (MG, 2%), and muscle-type acetylcholine receptor antibody (11%) was detected among NMO patients. The presence of neural or muscle autoantibodies was more common in NMO patients (34%) than in MS patients or healthy controls (7%), P < 0.0001. The coexistence of NMO and MG should be considered in atypical or refractory presentations of either disorder.

摘要

我们系统评估了177例视神经脊髓炎(NMO)患者以及250名对照受试者(173名健康者;77例多发性硬化症,MS,患者)的神经系统疾病、肌肉及神经自身抗体的出现频率。在NMO患者中检测到重症肌无力(MG,2%)及肌肉型乙酰胆碱受体抗体(11%)比例过高。NMO患者中神经或肌肉自身抗体的存在(34%)比MS患者或健康对照(7%)更为常见,P<0.0001。在任何一种疾病的非典型或难治性表现中,都应考虑NMO与MG共存的情况。

相似文献

1
Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica.重症肌无力与视神经脊髓炎中神经自身免疫血清学标志物的共存。
Muscle Nerve. 2009 Jan;39(1):87-90. doi: 10.1002/mus.21197.
2
Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.通过定量补体介导的对水通道蛋白4表达细胞的损伤来预测视神经脊髓炎发作的严重程度。
Arch Neurol. 2009 Sep;66(9):1164-7. doi: 10.1001/archneurol.2009.188.
3
HLA, PTPN22 and PD-1 associations as markers of autoimmunity in neuromyelitis optica.HLA、PTPN22 和 PD-1 标志物与视神经脊髓炎的自身免疫有关。
Mult Scler. 2012 Jan;18(1):23-30. doi: 10.1177/1352458511417480. Epub 2011 Sep 9.
4
Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis.抗水通道蛋白-4 抗体阳性的视神经脊髓炎与重症肌无力的关联。
J Neurol Sci. 2009 Dec 15;287(1-2):105-7. doi: 10.1016/j.jns.2009.08.040. Epub 2009 Sep 2.
5
Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis.双血清阴性重症肌无力患者中脂蛋白相关蛋白4自身抗体
Arch Neurol. 2012 Apr;69(4):445-51. doi: 10.1001/archneurol.2011.2393. Epub 2011 Dec 12.
6
The prevalence of long spinal cord lesions and anti-aquaporin 4 antibodies in neuromyelitis optica patients in Taiwan.在台湾的视神经脊髓炎患者中长脊髓病变和抗水通道蛋白 4 抗体的流行情况。
Eur Neurol. 2011;65(2):99-104. doi: 10.1159/000322740. Epub 2011 Jan 27.
7
NMO-IgG and Devic's neuromyelitis optica: a French experience.视神经脊髓炎免疫球蛋白(NMO-IgG)与德维克视神经脊髓炎:法国的经验
Mult Scler. 2008 May;14(4):440-5. doi: 10.1177/1352458507084595. Epub 2008 Jan 21.
8
Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.迟发性抗乙酰胆碱受体抗体血清阳性重症肌无力的发病率不断上升。
Neurology. 2005 Sep 27;65(6):928-30. doi: 10.1212/01.wnl.0000176067.32186.a3.
9
[Neuromyelitis optica spectrum disorders positive for anti-AQP4 antibody associated with myasthenia gravis: A literature review].抗水通道蛋白4抗体阳性的视神经脊髓炎谱系障碍合并重症肌无力:文献综述
J Fr Ophtalmol. 2019 Mar;42(3):e131-e132. doi: 10.1016/j.jfo.2018.06.018. Epub 2019 Feb 23.
10
NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy.重症肌无力但未行胸腺切除术患者的NMO-IgG阳性视神经脊髓炎
J Neurol Sci. 2008 Dec 15;275(1-2):148-50. doi: 10.1016/j.jns.2008.06.038. Epub 2008 Aug 13.

引用本文的文献

1
Clinical and immunological differences between primary and autoimmune-associated neuromyelitis optica spectrum disorders: a retrospective study.原发性与自身免疫相关的视神经脊髓炎谱系障碍的临床和免疫学差异:一项回顾性研究。
Lupus Sci Med. 2025 Apr 14;12(1):e001491. doi: 10.1136/lupus-2024-001491.
2
Scientific issues with rodent models of neuromyelitis optic spectrum disorders.视神经脊髓炎谱系障碍啮齿动物模型的科学问题
Front Immunol. 2024 Nov 19;15:1423107. doi: 10.3389/fimmu.2024.1423107. eCollection 2024.
3
Aquaporin4-IgG seropositivity significantly increases the risk of comorbid autoimmune diseases in NMOSD patients: population-based registry data.
水通道蛋白 4-IgG 血清阳性显著增加 NMOSD 患者合并自身免疫性疾病的风险:基于人群的登记数据。
J Neurol. 2024 Dec;271(12):7525-7536. doi: 10.1007/s00415-024-12698-2. Epub 2024 Sep 22.
4
Pregnancy characteristics in Egyptian female patients with NMOSD.埃及视神经脊髓炎谱系障碍女性患者的妊娠特征
Mult Scler J Exp Transl Clin. 2024 Aug 11;10(3):20552173241271878. doi: 10.1177/20552173241271878. eCollection 2024 Jul-Sep.
5
Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders.NMOSD 和 MOGAD 诊治进展:中枢神经系统自身免疫性炎症性疾病的两面。
Neurol Clin. 2024 Feb;42(1):77-114. doi: 10.1016/j.ncl.2023.06.009. Epub 2023 Aug 7.
6
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.视神经脊髓炎谱系疾病(NMOSD)的诊断和治疗进展 - 视神经脊髓炎研究组(NEMOS)的修订建议。第一部分:诊断和鉴别诊断。
J Neurol. 2023 Jul;270(7):3341-3368. doi: 10.1007/s00415-023-11634-0. Epub 2023 Apr 6.
7
Multi-Level Analyses of Genome-Wide Association Study to Reveal Significant Risk Genes and Pathways in Neuromyelitis Optica Spectrum Disorder.全基因组关联研究的多层次分析以揭示视神经脊髓炎谱系障碍中的显著风险基因和通路
Front Genet. 2021 Jul 21;12:690537. doi: 10.3389/fgene.2021.690537. eCollection 2021.
8
Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations.视神经脊髓炎谱系疾病与妊娠:治疗相关问题。
Nat Rev Neurol. 2020 Mar;16(3):154-170. doi: 10.1038/s41582-020-0313-y. Epub 2020 Feb 20.
9
Optic Neuritis.视神经炎
Continuum (Minneap Minn). 2019 Oct;25(5):1236-1264. doi: 10.1212/CON.0000000000000768.
10
Clinical characteristics of autoimmune disorders in the central nervous system associated with myasthenia gravis.与重症肌无力相关的中枢神经系统自身免疫性疾病的临床特征。
J Neurol. 2019 Nov;266(11):2743-2751. doi: 10.1007/s00415-019-09461-3. Epub 2019 Jul 24.